The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Astellas Pharma
Enfortumab vedotin (EV) in previously treated gastric/esophageal cancers cohorts of EV-202.
 
Kei Muro
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Lilly; MSD; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Chugai Pharma; Ono Pharmaceutical
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Chugai Pharma (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); PAREXEL International (Inst); PRA Health Sciences (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Keisho Chin
Speakers' Bureau - Bristol-Myers Squibb; Chugai Pharma; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
 
Steven Brad Maron
Honoraria - American Physician CME; Clarion Healthcare; Clinical Care Options; Medpage; MJH Healthcare Holdings, LLC; Oncoview; Physicans' Education Resource; Practicing Clinician Exchange; Vindico Medical Education
Consulting or Advisory Role - Amgen; Calcium; Daichi Sankyo; Elevation Oncology; Novartis; Pinetree Therapeutics; Purple Biotech
Research Funding - Epic Sciences; Guardant Health (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Fadi S. Braiteh
Honoraria - AstraZeneca; AstraZeneca; Daiichi Sankyo; Deciphera; Eisai; EMD Serono; Fresenius Kabi; Genentech/Roche; Guardant Health; Ipsen; Lilly; Seagan; Stemline Therapeutics
Consulting or Advisory Role - AstraZeneca; Deciphera; Eisai; Guardant Health; Ipsen; Lilly; Sanofi
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Deciphera; EMD Serono; Genentech/Roche; Guardant Health; Jazz Pharmaceuticals; Lilly; Pfizer; Seagan; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EMD Serono; Fresenius Kabi; Incyte; Novartis; Regeneron; Roche/Genentech; Stemline Therapeutics; Taiho Pharmaceutical
 
Seiichiro Mitani
Honoraria - Merck; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Chugai Pharma
Research Funding - Lilly; Taiho Pharmaceutical
 
Hiroki Hara
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo/UCB Japan; Lilly; Merck Serono; Miyarisan pharmaceutical; MSD; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo/UCB Japan; Ono Pharmaceutical
Research Funding - ALX Oncology (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Janssen Oncology (Inst); Jazz Pharmaceuticals (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Yasutoshi Kuboki
Honoraria - Lilly Japan; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Boehringer Ingelheim; Incyte; Janssen Oncology; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Carna Biosciences (Inst); Chugai Pharma (Inst); Daiichi Sankyo/UCB Japan (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen Oncology (Inst); Jiangsu Hengrui Pharmaceuticals (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Chugai Pharma; Incyte
 
Mary F Mulcahy
No Relationships to Disclose
 
Joaquina Celebre Baranda
Stock and Other Ownership Interests - Aprea Therapeutics; Merus NV; Moderna Therapeutics; Zymeworks
Research Funding - Astellas Pharma (Inst); Chungchun Intellicrown (Inst); Exelixis (Inst); IMPAC Medical Systems (Inst); Merck (Inst); Poseida (Inst); Sanofi (Inst); Synermore (Inst); Xencor (Inst)
 
Faithlore Patrice Gardner
Employment - Florida Cancer Specialists
Leadership - Florida Cancer Specialists
Speakers' Bureau - Regeneron
Research Funding - AstraZeneca; Genentech; Lilly; Lilly; Macrogenics; Novartis Pharmaceuticals UK Ltd.; Pfizer; Pharmacyclics; Roche; Verastem
 
Ning Jin
No Relationships to Disclose
 
Satoshi Hamauchi
Speakers' Bureau - Ono Pharmaceutical
 
Jason Kaplan
No Relationships to Disclose
 
Seema Rao Gorla
Employment - Astellas Pharma
Research Funding - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma
 
Shubin Liu
No Relationships to Disclose
 
Michele Wozniak
No Relationships to Disclose
 
Changting Meng
Employment - Karyopharm Therapeutics; Seagen
Stock and Other Ownership Interests - Karyopharm Therapeutics; Seagen
Travel, Accommodations, Expenses - Karyopharm Therapeutics; Seagen
 
Shunsuke Kondo
Honoraria - Chugai Pharma; Eisai; Sanofi
Speakers' Bureau - Chugai Pharma; Eisai
Research Funding - Abbvie (Inst); AZD (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Eisai (Inst); Incyte (Inst); Lilly (Inst)